• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMBU A/S VIVASIGHT 2 DLT KIT 39 FR - LEFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMBU A/S VIVASIGHT 2 DLT KIT 39 FR - LEFT Back to Search Results
Model Number 412391000
Medical Device Problem Code Structural Problem (2506)
Health Effect - Clinical Code Upper Respiratory Tract Injury (4599)
Date of Event 11/06/2024
Type of Reportable Event Serious Injury
Event or Problem Description
The incident leading to tonsil injuries occurred in two separate procedures (the second incident is covered by 9610691-2024-00023).A crna was trying to intubate with the vivasight 2 dlt product and they had to adjust the distance of tip of the tube past the vocal cords.The curve at the end of the bronchial lumen was more angulated than a typical robert-shaw double lumen endotracheal tube and got more easily caught on the tracheal rings.One could either advance the bronchial cuff further past the vocal cords with the stylet, or if the stylet was removed after the tip was in the trachea, one could turn the tube 120-180 degrees leftward while advancing and then return it to 90 degrees once past the ring that the tip got hung up on.
 
Additional Manufacturer Narrative
We verified the reported failure of the product's tip being bent, from the retention sample of the same manufacturing lot.Angle measurement from end to tip of endotracheal bevel was performed, in order to evaluate if the bending is within specifications (15°-53°).The angle of the retention sample was 60°, thus outside of specifications.Corrective action had been initiated to investigate this issue and the preliminary investigation showed that the bending was caused by mishandling by manufacturing personnel, in which additional bending of endobronchial tip occurred after stylet insertion process.There is an ongoing recall 'ambu2024fa00001' which was initiated due to hyperangulation of the distal tip.The lot number of the affected product involved in this incident corresponds to the lot numbers affected by the recall.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIVASIGHT 2 DLT KIT 39 FR - LEFT
Common Device Name
VIVASIGHT 2 DLT KIT 39 FR - LEFT
Manufacturer (Section D)
AMBU A/S
baltorpbakken 13
ballerup, 2750
DA  2750
Manufacturer (Section G)
AMBU SDN. BHD.
lintang bayan lepas 6
phase iv, lot 69b
penang, 11900
MY   11900
Manufacturer Contact
lenka vaculciakova
baltorpbakken 13
ballerup, 2750
DA   2750
MDR Report Key20850556
Report Number9610691-2024-00024
Device Sequence Number3758100
Product Code CBI
UDI-Device Identifier05707480145768
UDI-Public05707480145768
Combination Product (Y/N)N
Initial Reporter StateHI
Initial Reporter CountryUS
PMA/510(K) Number
K203749
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Remedial Action Recall,Replace,Inspection,Notification
Type of Report Initial
Report Date (Section B) 12/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number412391000
Device Catalogue Number412391000
Device Lot Number1000989835
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/06/2024
Initial Report FDA Received Date12/05/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/24/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
FDA REF.: Z-0261-2025, A
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-